{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:22Z","timestamp":1787772142967,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Early rheumatic heart disease (RHD) is characterized by valve regurgitation, leading to ventricular distention and possible elaboration of amino-terminal pro-brain natriuretic peptide (NT-proBNP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Thirty-one children with RHD were entered in the study. Transthoracic echocardiography was performed in all patients to assess the severity of the valve disease and cardiac function, thus will be classified into three groups: mild, moderate, and severe mitral valve regurgitation (MR), with and without left ventricular (LV) dilatation. At the time of echo, venous blood samples were drawn; thus, NT-proBNP levels were measured using sandwich immunoassay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The median NT-proBNP levels in mild, moderate, and severe MR were 32.34, 120.75, and 7094 pg\/ml, respectively. The median NT-proBNP levels in patients with and without LV dilatation were 3045 and 30.82 pg\/ml. There was a significant correlation between the severity of MR and NT-proBNP levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), thus a significant correlation between LV dilatation and NT-proBNP levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.013). A cutoff value of 2598.50 pg\/ml was obtained with a sensitivity value of 90% and a specificity of 90.5% for NT-proBNP levels against severe MR. A cutoff value of 199.35 pg\/ml was obtained with a sensitivity value of 73.3% and a specificity of 75% for NT-proBNP levels on LV dilatation. A cutoff value of 2598.50 pg\/ml was obtained with a sensitivity value of 85.7% and a specificity of 79.2% for NT-proBNP levels against severe MR with LV dilatation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>There was a significant relationship between NT-proBNP levels and the severity of MR and LV dilatation in children with RHD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijciis.ijciis_54_23","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T09:52:34Z","timestamp":1711533154000},"page":"43-50","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Predictor of mitral valve regurgitation severity and left ventricular dilatation using amino-terminal pro-brain natriuretic peptide marker in pediatric rheumatic heart disease"],"prefix":"10.4103","volume":"14","author":[{"given":"Dyahris","family":"Koentartiwi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Medical Faculty, Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurniawan Taufiq","family":"Kadafi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical Faculty, Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiqi Isnaini Nurul","family":"Hikmah","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical Faculty, Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takhta","family":"Khalasha","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Medical Faculty, Universitas Brawijaya, Malang, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardhanis","family":"Ramadhanti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical Faculty, Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renny","family":"Suwarniaty","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical Faculty, Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"R1-20240902","doi-asserted-by":"crossref","first-page":"e3562","DOI":"10.1097\/MD.0000000000003562","article-title":"Serum levels of IL-17 and IL-23 in patients with rheumatic mitral stenosis","volume":"95","author":"Bilik","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R2-20240902","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"R3-20240902","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0974-2069.79617","article-title":"Genes, autoimmunity and pathogenesis of rheumatic heart disease","volume":"4","author":"Guilherme","year":"2011","journal-title":"Ann Pediatr Cardiol"},{"key":"R4-20240902","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","article-title":"Rheumatic heart disease","volume":"379","author":"Marijon","year":"2012","journal-title":"Lancet"},{"key":"R5-20240902","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group a streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R6-20240902","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3111\/13696998.2015.1006366","article-title":"Echo-based screening of rheumatic heart disease in children:A cost-effectiveness Markov model","volume":"18","author":"Zachariah","year":"2015","journal-title":"J Med Econ"},{"key":"R7-20240902","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.rmed.2011.07.013","article-title":"Brain natriuretic peptide measurement in pulmonary medicine","volume":"105","author":"Salerno","year":"2011","journal-title":"Respir Med"},{"key":"R8-20240902","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12291-014-0474-9","article-title":"Bruns:Tietz fundamentals of clinical chemistry and molecular diagnostics","volume":"30","author":"Lopez","year":"2015","journal-title":"Indian J Clin Biochem"},{"key":"R9-20240902","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00246-008-9258-4","article-title":"NT-pro-B-type natriuretic peptide in infants and children:Reference values based on combined data from four studies","volume":"30","author":"Nir","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"R10-20240902","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/0974-2069.180668","article-title":"Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease","volume":"9","author":"Zachariah","year":"2016","journal-title":"Ann Pediatr Cardiol"},{"key":"R11-20240902","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/1995-705X.182648","article-title":"B-type natriuretic peptide as an index of symptoms and severity of chronic rheumatic mitral regurgitation","volume":"17","author":"Abdel Fattah","year":"2016","journal-title":"Heart Views"},{"key":"R12-20240902","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography:A scientific statement from the American heart association","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"R13-20240902","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrcardio.2012.7","article-title":"World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease \u2013An evidence-based guideline","volume":"9","author":"Rem\u00e9nyi","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"R14-20240902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3126\/njh.v16i2.26293","article-title":"Rheumatic heart disease in school going children:A cross-sectional epidemiological profile of Jajarkot, Nepal","volume":"16","author":"Regmi","year":"2019","journal-title":"Nepal Heart J"},{"key":"R15-20240902","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R16-20240902","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jamacardio.2015.0292","article-title":"Prevalence of subclinical rheumatic heart disease in Eastern Nepal:A school-based cross-sectional study","volume":"1","author":"Shrestha","year":"2016","journal-title":"JAMA Cardiol"},{"key":"R17-20240902","first-page":"3","article-title":"Characteristics of patients with rheumatic heart disease who were hospitalized at General Hospital of Dr. M. Djamil Padang. Djamil padang","volume":"4","author":"Hasnul","year":"2015","journal-title":"Andalas Health J"},{"key":"R18-20240902","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/heartjnl-2021-320356","article-title":"Clinical outcomes of children with rheumatic heart disease","volume":"108","author":"Zimmerman","year":"2022","journal-title":"Heart"},{"key":"R19-20240902","doi-asserted-by":"crossref","first-page":"455","DOI":"10.32883\/hcj.v5i2.779","article-title":"Mitral valve morphological changes in acute rheumatic fever and rheumatic heart disease","volume":"5","author":"Tito","year":"2020","journal-title":"Hum Care J"},{"key":"R20-20240902","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5334\/gh.1160","article-title":"Survival of rheumatic heart disease in Indonesian children","volume":"17","author":"Arafuri","year":"2022","journal-title":"Glob Heart"},{"key":"R21-20240902","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5114\/polp.2020.103507","article-title":"B-type natriuretic peptide and high sensitivity C-reactive protein in patients with rheumatic fever and rheumatic heart disease:Relationship to mitral regurgitation","volume":"95","author":"Elshamaa","year":"2021","journal-title":"Pediatr Pol Pol J Paediatr"},{"key":"R22-20240902","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.107.755942","article-title":"Left ventricular response to mitral regurgitation:Implications for management","volume":"118","author":"Gaasch","year":"2008","journal-title":"Circulation"},{"key":"R23-20240902","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fsurg.2020.00047","article-title":"Clinical profile and management of rheumatic heart disease in children and young adults at a tertiary cardiac center in Indonesia","volume":"7","author":"Lilyasari","year":"2020","journal-title":"Front Surg"},{"key":"R24-20240902","doi-asserted-by":"crossref","first-page":"e207285","DOI":"10.14503\/THIJ-20-7285","article-title":"Mitral regurgitation and serum N-terminal pro-brain natriuretic peptide levels in children:A modification of adult criteria","volume":"49","author":"Erolu","year":"2022","journal-title":"Tex Heart Inst J"}],"container-title":["International Journal of Critical Illness and Injury Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_54_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:31:06Z","timestamp":1787769066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_54_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijciis.ijciis_54_23","relation":{},"ISSN":["2229-5151","2231-5004"],"issn-type":[{"value":"2229-5151","type":"print"},{"value":"2231-5004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}